TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/10/25 20:56 | 7/8/25 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nougues Maximo F | CA | O | CFO | S.m | -34 | 3.53 | 0 | -10 | -4 | 204 | D | ||||||||||||||
1/3/25 19:33 | 1/2/25 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nougues Maximo F | CA | O | CFO | S | -32 | 3.15 | 0 | -10 | -6 | 152 | D | ||||||||||||||
7/18/24 19:11 | 7/17/24 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nougues Maximo F | CA | O | CFO | S | -15 | 3.70 | 0 | -4 | -2 | 163 | D | ||||||||||||||
7/2/24 21:22 | 7/2/24 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nougues Maximo F | CA | O | CFO | S | -17 | 3.27 | 0 | -5 | -3 | 167 | D | ||||||||||||||
1/5/24 18:49 | 1/3/24 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nougues Maximo F | CA | O | CFO | S | -70 | 4.49 | 0 | -16 | -11 | 129 | D | ||||||||||||||
7/6/23 19:12 | 7/3/23 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nougues Maximo F | CA | O | CFO | S | -49 | 3.31 | 0 | -15 | -9 | 144 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |